Feedback / Questions
AMI463 - Vall d’Hebron University Hospital, Amira Therapeutics
https://amiratx.com/index.php/amira-therapeutics-lead-compound-ami463-demonstrates-60-tumor-reduction-in-preclinical-oral-study/
 
Dec 15, 2025
 
SHARE THIS
  • Print
  • Email
  • More sharing
    Reddit
    StumbleUpon
    Delicious